TipRanks
Advertisement
Advertisement

ANTX Stock Latest News

AN2 announces extension of funding for tuberculosis research collaboration
The FlyAN2 announces extension of funding for tuberculosis research collaboration
4d ago
GSK
ANTX
AN2 Therapeutics presents clinical data supporting development of Epetraborole
PremiumThe Fly
AN2 Therapeutics presents clinical data supporting development of Epetraborole
1M ago
ANTX
AN2 Therapeutics appoints Trenor as Chief Medical Officer
PremiumThe Fly
AN2 Therapeutics appoints Trenor as Chief Medical Officer
1M ago
ANTX
AN2 Therapeutics reports Q2 EPS (18c), two estimates (24c)
PremiumThe Fly
AN2 Therapeutics reports Q2 EPS (18c), two estimates (24c)
2M ago
ANTX
Analyst Sees Material Upside for AN2 Therapeutics as Epetraborole Targets Underserved Polycythemia Vera Market
PremiumRatings
Analyst Sees Material Upside for AN2 Therapeutics as Epetraborole Targets Underserved Polycythemia Vera Market
2M ago
ANTX
AN2 Therapeutics initiated with a Buy at Guggenheim
PremiumThe FlyAN2 Therapeutics initiated with a Buy at Guggenheim
2M ago
ANTX
AN2 Therapeutics initiated with a Buy at Guggenheim
Premium
The Fly
AN2 Therapeutics initiated with a Buy at Guggenheim
2M ago
ANTX
One new option listing on July 17th
Premium
The Fly
One new option listing on July 17th
3M ago
ANTX
AN2 Therapeutics Holds 2026 Annual Stockholder Meeting
PremiumCompany Announcements
AN2 Therapeutics Holds 2026 Annual Stockholder Meeting
4M ago
8K
ANTX
AN2 Therapeutics Advances Chagas Candidate After Positive Trials
PremiumCompany Announcements
AN2 Therapeutics Advances Chagas Candidate After Positive Trials
4M ago
8K
ANTX
AN2 Therapeutics reports data from two studies of AN2-502998 in Chagas disease
PremiumThe Fly
AN2 Therapeutics reports data from two studies of AN2-502998 in Chagas disease
4M ago
ANTX
AN2 Therapeutics upgraded to Outperform from Market Perform at Leerink
PremiumThe Fly
AN2 Therapeutics upgraded to Outperform from Market Perform at Leerink
5M ago
ANTX
AN2 Therapeutics reports Q1 EPS (29c), one estimate (23c)
PremiumThe FlyAN2 Therapeutics reports Q1 EPS (29c), one estimate (23c)
5M ago
ANTX
AN2 Therapeutics, Inc. (ANTX) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
AN2 Therapeutics, Inc. (ANTX) Q1 Earnings Cheat Sheet
5M ago
ANTX
AN2 Therapeutics Completes First-in-Human Trial, Setting Up the Next Catalyst for ANTX
Premium
Company Announcements
AN2 Therapeutics Completes First-in-Human Trial, Setting Up the Next Catalyst for ANTX
5M ago
ANTX
AN2 Therapeutics Launches New $80 Million ATM Program
PremiumCompany Announcements
AN2 Therapeutics Launches New $80 Million ATM Program
6M ago
8K
ANTX
AN2 Therapeutics files $300M mixed securities shelf
PremiumThe Fly
AN2 Therapeutics files $300M mixed securities shelf
6M ago
ANTX
AN2 Therapeutics announces initiation of Phase 2 trial of epetraborole
PremiumThe Fly
AN2 Therapeutics announces initiation of Phase 2 trial of epetraborole
6M ago
ANTX
AN2 Therapeutics Reprices Stock Options to Enhance Retention
PremiumCompany Announcements
AN2 Therapeutics Reprices Stock Options to Enhance Retention
7M ago
8K
ANTX
AN2 Therapeutics reports Q4 EPS (29c) vs (25c) last year
PremiumThe FlyAN2 Therapeutics reports Q4 EPS (29c) vs (25c) last year
7M ago
ANTX
AN2 Therapeutics Announces $40 Million Private Placement Financing
Premium
Company Announcements
AN2 Therapeutics Announces $40 Million Private Placement Financing
7M ago
8K
ANTX
AN2 Therapeutics to advance oral Epetraborole into Phase 2 study
Premium
The Fly
AN2 Therapeutics to advance oral Epetraborole into Phase 2 study
7M ago
ANTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >